Prozac Articles
First Approval Of P&U's Reboxetine
23 April 1997
US Rx Wholesale Prices "Up 1.8% In 1996"
3 March 1997
US Rx Drug Sales For 1996 Up 10% At $85.35 Billion
24 February 1997
New Products Drive Strong Growth At SB
24 February 1997
Significant Increases For US Drug Firms In 1996
3 February 1997
Lilly Forecasts Strong Sales For Prozac
27 January 1997
UK Rx Medicines Code Of Practice Report
20 January 1997
Zocor "Will Be World's Top-Selling Drug In 2005"
13 January 1997
Astra's Losec "World's No One Drug In 1998-2000"
16 December 1996
New Bulimia Indication For Prozac In USA
2 December 1996
Prozac Data Sheet Change In UK
18 November 1996
Zoloft Gets OCD Indication
4 November 1996
US Quarterly Results Show Improvements
4 November 1996
Novopharm Wins Generic Prozac Battle
7 October 1996
Organon's Remeron Is "Better Than Prozac"
30 September 1996
Eli Lilly To Offer Advice To Prozac Patients
23 September 1996
Lilly Signs $100 Million Antibiotic Deal With Dura
2 September 1996
Pfizer Rapped Over Zoloft Clams
19 August 1996
SmithKline Beecham: A Leader In Spanish Market
19 August 1996
Dilemma For Imported Drugs In China
5 August 1996
NEW YORK STOCK COMMENT
29 July 1996
Prozac Cost Savings Not Supported
29 July 1996
US Drug Majors See 2nd-Half Double-Digit Growth
29 July 1996
First Combination Therapy For Bulimia
8 July 1996
New Italo/US Group Seeks UK, Other Alliances
1 July 1996
New York Stock Comment
3 June 1996
More Expansion In Eastern Europe By ICN
27 May 1996
World Drug Sales Rise 9% In January 1996
6 May 1996
Generics Impact On Eli Lilly But Prozac Strong
22 April 1996
Barr Mounts Challenge To US Patents For Prozac
22 April 1996
Lilly Gets Interim Injunction on Prozac
1 April 1996
New York Stock Comment
1 April 1996
Premarin Heads Top-10 Prescription Drugs
1 April 1996
World Pharma Sales Up 11.6% In 1995, Says PMSI
18 March 1996
Medi-Cal Formulary Additions
4 March 1996
NEW YORK STOCK COMMENT
4 March 1996
Prozac In California
26 February 1996
Losec "Will Be The World's Top-Selling Drug In 2000"
26 February 1996
Mixed Earnings But Strong Sales For US Companies
12 February 1996
Antidepressant Growth "Well Above Average"
22 January 1996
All Change For Top Drugs In Year 2000: Lehman Bros
15 January 1996
Israel Views Controversial Patent Law Reforms
15 January 1996
New York stock comment
6 November 1995
Antidepressants may work for fibromyalgia...
30 October 1995
US 3rd Qrt Results: Strong Gains For Pfizer, Lilly
23 October 1995
France's Pharma Market Set To Grow 6.3% PA To 2000
18 September 1995
Eli Lilly loses court case for Prosac in Israel
11 September 1995
Teva wins Prosac dispute with Lilly
7 August 1995
Modest Rises For Rx Drug Prices At Half-Year
7 August 1995
Net Profits Down At Eli Lilly In 2nd Qtr
24 July 1995
US Sales of Generic Drugs Up 29% In 1994, Says IMS
17 July 1995
Solid 2nd Qtr Earnings Growth For US Drugmakers
17 July 1995
Eli Lilly Set For Overseas Expansion
10 July 1995
Elli Lilly protects rights on Prozac
19 June 1995
Novopharm's fluoxetine
19 June 1995
Disease ManagementThe Way Forward
15 May 1995
Growth Forecasts For Antidepressant Drugs
8 May 1995
Weaker US Dollar And Volume Growth Lift 1st Qtr
24 April 1995
Teva Says Israeli Patent Law Hinders Generics Progress
27 March 1995
Mood Disorders Market Set To Grow To $9.5 Bill By 2004
27 March 1995
20 Leading US Drugs' Price Increases Slammed
27 March 1995
Sepracor Moving Ahead In Its Chirality Field
13 March 1995
Dealing With PharmaIndustry Discipline
20 February 1995
Good Year for Eli Lilly Driven By Prozac
20 February 1995
Israeli MoH Opposes Patent Extension
6 February 1995
US Far-Right Groups Target The FDA
6 February 1995
French drug Market "Will Decline 2%-4% This Year"
23 January 1995
MCI Fined In USA
23 January 1995
Prozac Advertising Account Move
16 January 1995
UK Approval For Efexor; Comparative Data
16 January 1995
IMS Studies US Retail Drug Payments
16 January 1995
Serzone Priced At Discount To SSRIs In USA
16 January 1995
Prozac Positive Ruling
19 December 1994
Solvay Gains Luvox Approval From FDA
19 December 1994
Lilly Withdraws Lovan Approval Application
21 November 1994
South African Pharma Market $4 Billion In 2002
21 November 1994
US 3rd Quarter Shows Growth Despite Pressures
24 October 1994
USA's Top-Selling Drugs In 1993
24 October 1994
DDT's New Global Pharma Market Review 1994
10 October 1994
Effexor Superior To Prozac?
10 October 1994
NEW YORK STOCK COMMENT
26 September 1994
Eli Lilly Raises Profits Forecast, Extends PCS Offer Again
26 September 1994
Luvox Approvable For OCD In USA
12 September 1994
Glaxo Rumored To Be Eying Eli Lilly
22 August 1994
Forecasts For Growth In Euro Psychotropic Markets
22 August 1994
Benefits From PBM/MPC Acquisitions Assessed
15 August 1994
US Biotech Cos Top Earnings At 1st Half
25 July 1994
LILLY TO SELL NON-CORE BUSINESSES
27 June 1994
CNS DISORDERS IN THE COMING DECADE
16 May 1994
NEW PLAYER IN US DEPRESSION MARKET
25 April 1994
FDA REVIEW FOR DERACYN AND PROZAC
4 April 1994
NEW YORK STOCK COMMENT
4 April 1994
PROZAC APPROVED FOR OCD IN USA
14 March 1994
NEW YORK STOCK COMMENT
7 March 1994
ELI LILLY SEEKS FRENCH ACQUISITION
21 February 1994
RESTRUCTURING CHARGES DEPRESS LILLY AND E KODAK
14 February 1994
NEW APPROVALS CHANGE DEPRESSION MARKET
17 January 1994
FDA YEAR-END APPROVALS FOR 1993
10 January 1994
WORLD MARKETS FOR CNS AND GASTROINTESTINALS
13 December 1993
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
